"Candida auris": drug‑resistant opportunistic fungus that colonises the skin
Fungal infections caused by Candida auris have increased in recent decades and have become one of the main causes of death among hospitalised patients. Resistance to medicines and even climate change are some of the factors highlighted by researcher Catarina Pimentel for the spread of this opportunistic pathogen, which was detected in Portugal for the first time in 2022 and which can colonise our skin without us knowing.
INSA clarifies that the first case of Candida auris in Portugal was detected in 2022
Instituto Ricardo Jorge also reports that there were additional cases between 2022 and 2025 in public hospitals in the North and Lisbon and Tagus Valley Health Regions.
Drug-resistant fungus detected in Portugal for first time
Portuguese researchers have identified the country’s first confirmed cases of infection with Candida auris, a drug-resistant fungus considered a growing global public health threat. The cases were detected in 2023 The post Drug-resistant fungus detected in Portugal for first time appeared first on Portugal Resident.
Study identifies the first cases of Candida auris in Portugal and underscores the importance of surveillance
Candida auris is a drug-resistant fungus considered a global public health threat, with confirmed spread across multiple continents.
Candida auris: what you need to know about this fungus - dangers, protection, transmission, risk factors, treatment
A team of researchers led by the Faculty of Medicine at the University of Porto (FMUP) studied the first confirmed cases in Portugal of infection with Candida auris, a drug-resistant fungus considered a global public health threat.
First cases of drug-resistant fungus identified in Portugal — Candida auris
This fungus is considered a global public health threat.
First cases of Candida auris detected in Portugal
Researchers report Portugal's first identified cases of Candida auris, a drug‑resistant fungal pathogen of concern in healthcare settings; outlets say the finding underscores the need for strengthened surveillance and infection‑control measures. Those receiving care in hospitals and long‑term facilities should expect heightened attention to hygiene protocols and, where relevant, screening or isolation procedures.
Candida auris is an emerging, often multidrug‑resistant yeast that can cause serious bloodstream and invasive infections, especially in hospitalized or immunocompromised patients. It spreads in healthcare settings, can persist on surfaces, is hard to treat with standard antifungals, and the first identified cases in Portugal are significant for hospital infection‑control measures rather than indicating widespread community risk.